Latest news
Supernus and Indivior Partner in 2 Billion CNS Biopharma Merger - sekbernews.idsekbernews.id · Tue, 04 Aug 2026 12:26:23 GMTSupernus and Indivior to Merge, Forming a New CNS-Focused Pharma Company - MedCity NewsMedCity News · Mon, 03 Aug 2026 19:58:54 GMTSupernus And Indivior Merger: There May Be Some Skepticism, But I Have Faith In This Deal - Seeking AlphaSeeking Alpha · Mon, 03 Aug 2026 19:44:45 GMTSupernus, Indivior merge to create CNS-focused company and expand BD opportunities - Fierce PharmaFierce Pharma · Mon, 03 Aug 2026 15:20:52 GMTSupernus to Combine with Indivior To Form CNS Biopharmaceutical Leader with Potential $2 Billion in Revenue - BenzingaBenzinga · Mon, 03 Aug 2026 14:44:26 GMTCNS-focused Supernus and Indivior agree merger terms - pharmaphorumpharmaphorum · Mon, 03 Aug 2026 12:20:13 GMT